Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer

BMC Cancer. 2007 Mar 14:7:45. doi: 10.1186/1471-2407-7-45.

Abstract

Background: IL-1beta has been implicated in inflammatory episode. In view of the inflammatory nature of cancer cachexia, we determined the predictive value of IL-1B-31 T/C, -511 C/T, +3954 C/T and IL-1RN VNTR gene polymorphisms on the occurrence of cachexia associated with locally advanced gastric cancer.

Methods: The study included 214 patients and 230 healthy volunteers. Genomic DNA was prepared from peripheral blood leukocytes. Genotypes and allele frequencies were determined in patients and healthy controls using restriction fragment length polymorphism analysis of polymerase chain reaction products.

Results: The overall frequencies of IL-1B-31 T, -511 T, +3954 T and IL-1RN VNTR alleles in patients with locally advanced gastric cancer were all comparable with those in controls. No significant differences were found in the distribution of IL-1B-31 T, -511 T and IL-1RN VNTR between patients with cachexia and without. Patients with cachexia showed a significantly higher prevalence of IL-1B+3954 T allele than those without (P = 0.018). In a logistic regression analysis adjusted for actual weight, carcinoma location and stage, the IL-1B+3954 CT genotype was associated with an odds ratio of 2.512 (95% CI, 1.180 - 5.347) for cachexia.

Conclusion: The IL-1B+3954 T allele is a major risk for cachexia from locally gastric cancer. Genetic factors studied are not likely to play an important role in the determination of susceptibility to locally advanced gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cachexia / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Markers
  • Genotype
  • Humans
  • Interleukin-1beta / genetics*
  • Logistic Models
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Prospective Studies
  • Stomach Neoplasms / complications*

Substances

  • Genetic Markers
  • Interleukin-1beta